315
Views
0
CrossRef citations to date
0
Altmetric
Assessment Procedures

Psychometric evaluation of the Fear of Cancer Recurrence Inventory (FCRI) and development of a short version in patients with follicular lymphoma

ORCID Icon, , , ORCID Icon, & ORCID Icon
Pages 7508-7515 | Received 07 Apr 2021, Accepted 22 Sep 2021, Published online: 08 Oct 2021
 

Abstract

Purpose

To evaluate the psychometric properties of the Chinese Fear of Cancer Recurrence Inventory (FCRI-C) in follicular lymphoma (FL) survivors.

Materials and methods

A nationwide cross-sectional study was conducted online between July and September 2020. The following psychometric properties of the FCRI-C were evaluated: construct, convergent, and discriminant validity, and reliability. Item variance was assessed using differential item functioning (DIF). A short version of the FCRI-C was developed using a two-parameter item response theory (IRT) model. The patterns of response scale, item fit, and item information were assessed. The receiver operating characteristic (ROC) curve was used to determine the clinical cut-off point for the FCRI-C.

Results

A total of 326 FL survivors completed the questionnaire. The confirmatory factor analysis supported the bi-factor structure of the FCRI-C. The IRT analysis confirmed a 10-item short version of the FCRI-C. Satisfactory convergent and discriminant validity were underpinned by a priori hypotheses. Cronbach’s alpha of 0.95 and intraclass correlation coefficient of 0.82 indicated good internal consistency and test–retest reliability. The ROC curve determined a cut-off point of 83 and 20 for the full and short versions, respectively.

Conclusions

The FCRI-C used to measure and screen the levels of FCR in Chinese FL survivors was found to be valid and reliable.

    Implications for Rehabilitation

  • The Chinese Fear of Cancer Recurrence Inventory (FCRI-C) is a reliable and valid measure to evaluate the fear of cancer recurrence (FCR) in follicular lymphoma survivors.

  • The short version of the FCRI-C provides a rapid screening tool for the clinical detection of FCR in patients.

  • The cut-off point of the FCRI-C could differentiate patients between “high” and “low” levels of FCR in clinical practice.

Acknowledgements

The authors thank Dr. Sébastien Simard for his generous provision of the Chinese version of the FCRI. We deeply appreciate the patients with follicular lymphoma and their caregivers who participated in the study. We are grateful to Mr. Gu Hongfei and Ms. Chang Di from the House086 for facilitating this research.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 374.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.